- Home
- REFI vs JSPR Comparison
REFI vs JSPR Comparison
Compare REFI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- JSPR
- Stock Information
- Founded
- REFI 2021
- JSPR 2018
- Country
- REFI United States
- JSPR United States
- Employees
- REFI N/A
- JSPR N/A
- Industry
- REFI Real Estate Investment Trusts
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REFI Real Estate
- JSPR Health Care
- Exchange
- REFI Nasdaq
- JSPR Nasdaq
- Market Cap
- REFI 304.4M
- JSPR 85.8M
- IPO Year
- REFI 2021
- JSPR N/A
- Fundamental
- Price
- REFI $13.95
- JSPR $2.87
- Analyst Decision
- REFI Strong Buy
- JSPR Buy
- Analyst Count
- REFI 3
- JSPR 12
- Target Price
- REFI $20.00
- JSPR $31.67
- AVG Volume (30 Days)
- REFI 102.2K
- JSPR 1.1M
- Earning Date
- REFI 08-06-2025
- JSPR 08-12-2025
- Dividend Yield
- REFI 13.48%
- JSPR N/A
- EPS Growth
- REFI N/A
- JSPR N/A
- EPS
- REFI 1.88
- JSPR N/A
- Revenue
- REFI $56,790,054.00
- JSPR N/A
- Revenue This Year
- REFI $15.53
- JSPR N/A
- Revenue Next Year
- REFI $6.70
- JSPR N/A
- P/E Ratio
- REFI $7.42
- JSPR N/A
- Revenue Growth
- REFI 4.68
- JSPR N/A
- 52 Week Low
- REFI $12.76
- JSPR $2.27
- 52 Week High
- REFI $16.47
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- REFI 41.47
- JSPR 29.07
- Support Level
- REFI $13.85
- JSPR $2.27
- Resistance Level
- REFI $14.41
- JSPR $7.19
- Average True Range (ATR)
- REFI 0.26
- JSPR 0.60
- MACD
- REFI -0.01
- JSPR -0.33
- Stochastic Oscillator
- REFI 13.16
- JSPR 12.37
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.